Indonesia's Agency for Food and Drug Control (BPOM) Holds Workshop on Vaccine Quality Management

Jun 16, 2013 19:00 JST

Source: PT Bio Farma (Persero)

Bandung, W Java, Indonesia, Jun 16, 2013 - (ACN Newswire) - Indonesia's Agency for Food and Drug Control (BPOM) is to hold a workshop on the quality management for vaccine making of which it has good experience to share with member states of the Organization of Islamic Conference (OIC).

The workshop is to be held on 17 June 2013 alongside the on-going 2nd meeting of vaccine- and medicine-manufacturers of OIC member states in the city of Bandung, West Java province. Delegates and experts from nine countries that already have their vaccine making facilities out of the total 57 OIC member countries are attending the meeting which runs from 16 to 19 June, 2013.

The BPOM workshop is aimed sharing Indonesian experience with other OIC member states on strengthening National Regulation Authority (NRA)'s function in vaccine manufacturing for global markets. NRAs are national regulatory agencies responsible for ensuring that products released for public distribution (normally pharmaceuticals and biological products, such as vaccines) are evaluated properly and meet international standards of quality and safety.

Countries producing vaccines need to exercise six critical control functions, and exercise them in a competent and independent manner, backed up with enforcement power. The six functions are a published set of requirements for licensing, surveillance of vaccine field performance, system of lot release, use of laboratory when needed, regular inspections for good manufacturing practices (GMP) and clinical performance evaluation.

The workshop will start with keynote remarks by BPOM head Lucky S. Slamet, said workshop organizers. Bio Farma will take part in the workshop and share the experiences that the 123-year old vaccine making company has, organizers said.

Bio Farma Sales & Marketing Director Dr. Mahendra Suhardono is scheduled to speak on quality management system (Manufacture, Pre Qualification of Vaccine) in a way to meeting the GMP as set out by the WHO for its prequalification so that the vaccine products are exportable.

Dr. Suhardono is expected to speak about how Bio Farma has been able to maintain an integrated system of quality control management and efforts on keeping it update with latest GMP requirements. Bio Farma is Indonesia's only vaccine manufacturer whose products have been recognized by WHO since 1997, so that the company can supply its products to over 120 countries worldwide.

Currently the needs for Expanded Program on Immunization (EPI) vaccines in Indonesia have been supplied solely by Bio Farma by producing and distributing over 1.7 billion doses of vaccine per year to meet the needs of EPI vaccine for national immunization program.

Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its EPI vaccine products, and has also implemented green industry and is environmently friendly. WHO acknowledges that Bio Farma vaccine products are of high quality, efficacious, and affordable.

Bio Farma products are through the direct distribution or through various agencies such as UNICEF and PAHO. The company has obtained the Best Export Performance from the Indonesian Trade Ministry consecutively in 2010,2011, 2012 as evidence of its consistent exceptional performance.

Contact:

M. Rahman Rustan  
Corporate Secretary 
Bio Farma 
+62 22 2033755
+62 22 2041306
pr@biofarma.co.id

Source: PT Bio Farma (Persero)
Sectors: BioTech

Related Press Release

Bio Farma secures Multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2)

October 04 2022 07:00 JST

Bio Farma to Export its Polio Vaccine After Securing Purchase Contracts from UNICEF for 2022 and 2023

September 30 2022 18:00 JST

Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines

September 09 2022 17:00 JST

9th International Conference on Typhoid, Invasive NTS Disease Held in Bali, Indonesia

May 01 2015 14:00 JST

Bio Farma Rolls Out Pentavalent Vaccine to All Provinces of Indonesia in 2014

December 09 2014 13:00 JST

Bio Farma Continues Presidency of the Developing Country Vaccine Manufacturers Network (DCVMN)

December 05 2014 19:00 JST

Bio Farma Awarded Gold PROPER by the Indonesian Ministry Of Environment & Forestry

December 04 2014 18:00 JST

Indonesia as the Hub of Excellence for Biological Products for Islamic Countries

October 23 2013 16:30 JST

Bio Farma Launches Pentavalent Vaccine, Combining Five Antigens

August 24 2013 12:00 JST

Bio Farma Holds Third Indonesian Vaccine Research Forum

July 02 2013 21:00 JST

More Press release >>

Latest Press Release

Mitsubishi Motors to Display Custom Versions of the Triton at Tokyo Auto Salon 2025
Jan 07, 2025 15:41 JST

'Toyota Woven City,' a Test Course for Mobility, Completes Phase 1 Construction and Prepares for Launch
Jan 07, 2025 15:25 JST

Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer's Disease
Jan 07, 2025 09:14 JST

Toyota to Share Progress on Woven City at CES 2025
Jan 06, 2025 15:49 JST

Mazda to build Module Pack Plant for Cylindrical Lithium-ion Batteries for Automotive Use in Iwakuni City, Yamaguchi Prefecture
Jan 06, 2025 15:36 JST

Galaxy Payroll Group Limited and People Intelligence Singapore Pte. Ltd. Announce Strategic Partnership
Jan 03, 2025 20:41 JST

Gruelling Challenge Awaits TGR In Saudi Arabia
Dec 27, 2024 15:20 JST

The General Incorporated Association Generative AI Japan Announces the Winners of the Japan Generative AI Award 2024
Dec 27, 2024 11:00 JST

MHI Included in "World Index" of Dow Jones Sustainability Index for Second Consecutive Year
Dec 27, 2024 09:36 JST

TOYOTA GAZOO Racing to Exhibit at Tokyo Auto Salon 2025
Dec 26, 2024 17:11 JST

JCB Launches Red Guahan Shopping Mall Shuttle Free Ride Promotion in Guam
Dec 26, 2024 12:00 JST

Mazda Production and Sales Results for November 2024
Dec 26, 2024 11:46 JST

MHI Conducts Nighttime and Long-Distance Highway Demonstration Testing of Unmanned Aerial Vehicle Currently Under Development
Dec 26, 2024 09:47 JST

Hitachi delivers a turnkey rail solution for Ho Chi Minh City's first urban railway Line 1 in Vietnam
Dec 24, 2024 13:19 JST

Nissan and Honda sign MOU to consider business integration
Dec 24, 2024 11:18 JST

Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year
Dec 24, 2024 11:00 JST

GAC Honda Begins Operation of New Energy Vehicle (NEV) Production Factory in Guangzhou, China
Dec 24, 2024 10:23 JST

Sarawak Premier Makes Inaugural Visit to Mitsubishi Power's Takasago Hydrogen Park
Dec 24, 2024 10:10 JST

Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
Dec 23, 2024 17:22 JST

Nissan, Honda, and Mitsubishi Motors sign MOU on collaborative considerations
Dec 23, 2024 13:54 JST

More Latest Release >>